The Open Biochemistry Journal




ISSN: 1874-091X ― Volume 13, 2019

Screening Outside the Catalytic Site: Inhibition of Macromolecular Interactions Through Structure-Based Virtual Ligand Screening Experiments



Olivier Sperandio1, Maria A Miteva1, Kenneth Segers2, Gerry A. F Nicolaes2, Bruno O Villoutreix*, 1
1 Inserm U648, University of Paris 5, 45 rue des Sts Peres, 75006 Paris, France
2 Department of Biochemistry, Cardiovascular Research Institute Maastricht, Maastricht University, the Netherlands

Abstract

During these last 15 years, drug discovery strategies have essentially focused on identifying small molecules able to inhibit catalytic sites. However, other mechanisms could be targeted. Protein-protein interactions play crucial roles in a number of biological processes, and, as such, their disruption or stabilization is becoming an area of intense activity. Along the same line, inhibition of protein-membrane could be of major importance in several disease indications. Despite the many challenges associated with the development of such classes of interaction modulators, there has been considerable success in the recent years. Importantly, through the existence of protein hot-spots and the presence of druggable pockets at the macromolecular interfaces or in their vicinities, it has been possible to find small molecule effectors using a variety of screening techniques, including combined virtual ligand-in vitro screening strategy. Indeed such in silico-in vitro protocols emerge as the method of choice to facilitate our quest of novel drug-like compounds or of mechanistic probes aiming at facilitating the understanding of molecular reactions involved in the Health and Disease process. In this review, we comment recent successes of combined in silico-in vitro screening methods applied to modulating macromolecular interactions with a special emphasis on protein-membrane interactions.

Keywords: Virtual screening, structure-based drug design, drug discovery, protein-protein interaction, protein-membrane interaction.


Article Information


Identifiers and Pagination:

Year: 2008
Volume: 2
First Page: 29
Last Page: 37
Publisher Id: TOBIOCJ-2-29
DOI: 10.2174/1874091X00802010029

Article History:

Received Date: 20/1/2008
Revision Received Date: 8/2/2008
Acceptance Date: 23/2/2008
Electronic publication date: 10/3/2008
Collection year: 2008

Article Metrics:

CrossRef Citations:
0

Total Statistics:

Full-Text HTML Views: 1855
Abstract HTML Views: 1141
PDF Downloads: 263
Total Views/Downloads: 3259

Unique Statistics:

Full-Text HTML Views: 807
Abstract HTML Views: 619
PDF Downloads: 174
Total Views/Downloads: 1600
Geographical View

2008 Bentham Science Publishers Ltd


* Address correspondence to this author at the Inserm U648, University of Paris 5, 45 rue des Sts Peres, 75006 Paris, France; E-mail: bruno.villoutreix@univ-paris5.fr


Endorsements



"We have always had a fruitful cooperation and long-term experience of publishing with Bentham Open."

"A number of our original papers have appeared in its different journals, as the Bentham Open Publishers provides sufficient research in the field of science and technologies (belonging to the pharmaceutical, biotechnology, biomedical industries etc). The staff of the Bentham Open always treat our papers very seriously and gently during the rutile paper reviewing process, so far we always felt their kindness and highly cooperative support. Today, Bentham Open is providing a great support to science and research, giving opportunities of high standard publishing as well as promoting and enhancing selected papers around the world through communication and exchange of global scientific education."


Kholmirzo T. Kholmurodov
Leading Scientist
FLNP (Frank Laboratory of Neutron Physics) JINR (Joint Institute of Nuclear Research) Moscow region, Russia


Browse Contents



Webmaster Contact: info@benthamopen.net
Copyright © 2019 Bentham Open